MedTrace Logo

Chlorhexidine Gluconate Oral Care for Adults Experiencing Trauma

NCT01382446 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2017-02-06

Study results available
· View outcomes & findings →

Summary

Examine the use of 0.12% Chlorhexidine Gluconate as an adjunct to current oral care protocol for trauma patients on ventilator support to decrease the incidence of Ventilator Associated Pneumonia and oral bacterial load.

Conditions

  • Ventilator Associated Pneumonia

Interventions

DRUG

Chlorhexidine gluconate

0.12% Chlorhexidine Gluconate 15ml Twice Daily, administered via toothbrushing and swabbing teeth, tongue, gingiva, and oral mucosa.

OTHER

Toothpaste

Brushing the teeth, tongue, gingiva, and oral mucosa twice daily with toothbrush and toothpaste.

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • St. Joseph's Hospital and Medical Center, Phoenix

    lead OTHER

Principal Investigators

  • Tracy Thomas, MSN · St. Joseph's Hospital and Medical Center, Phoenix

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01382446 on ClinicalTrials.gov